Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inducible nitric oxide synthase (iNOS), also known as NOS2, is an enzyme responsible for the high-output production of nitric oxide (NO) in response to inflammatory stimuli. Unlike other isoforms of nitric oxide synthase, iNOS is not constitutively expressed but is induced primarily by cytokines and bacterial products. The enzyme plays a key role in immune defense mechanisms and inflammation. Overexpression or dysregulation of iNOS has been implicated in various diseases, including sepsis, osteoarthritis, cancer, and chronic kidney disease. It is considered a therapeutic target for selective inhibition strategies.
Selective inhibition strategies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric Oxide Synthase, Inducible (iNOS).